Key points are not available for this paper at this time.
This protocol can be used in the diagnostic work-up of low-grade myelodysplastic syndromes patients who lack specific diagnostic markers, although further improvement in diagnostic power is desirable.
Ogata et al. (Mon,) studied this question.